Stocks › AXSM
Axsome Therapeutics AXSM
US equityMarket cap rank #1751
$129.36 −$6.32 (-4.66%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $129.36 0.00%
Open$133.92
Prev close$135.68
Day range$128.23 – $135.09
Volume811.8K
Market cap$6.80B
P/E (TTM)–
Dividend yield–
Analyst view
ConsensusBuy
Analysts17
Average target$263.94+104.0% vs. price
- Buy 94%
- Hold 6%
Low $220.00Now $129.36Avg $263.94High $310.00
Recent rating changes
The last 20 actions on file set price targets from $220.00 to $310.00, averaging $259.65.
| Date | Firm | Rating | Target |
|---|---|---|---|
| 13 Nov 2026 | Morgan Stanley | HOLD | $223.00 |
| 9 Nov 2026 | H.C. Wainwright | BUY | $290.00 |
| 4 Nov 2026 | Mizuho Securities | BUY | $272.00 |
| 3 Nov 2026 | Wells Fargo | BUY | $256.00 |
| 3 Nov 2026 | UBS | BUY | $239.00 |
| 3 Nov 2026 | Baird | BUY | $220.00 |
| 3 Nov 2026 | Morgan Stanley | HOLD | $249.00 |
| 3 Nov 2026 | Deutsche Bank | BUY | $245.00 |
| 3 Nov 2026 | Guggenheim | BUY | $250.00 |
| 2 Nov 2026 | Cantor Fitzgerald | BUY | $272.00 |
| 2 Nov 2026 | UBS | BUY | $239.00 |
| 2 Nov 2026 | Piper Sandler | BUY | $235.00 |
| 2 Nov 2026 | BofA Securities | BUY | $264.00 |
| 2 Nov 2026 | Morgan Stanley | HOLD | $249.00 |
| 2 Nov 2026 | Jefferies | BUY | $305.00 |
| 2 Nov 2026 | BMO Capital | BUY | $310.00 |
| 2 Nov 2026 | RBC Capital | BUY | $273.00 |
| 29 Oct 2026 | Mizuho Securities | BUY | $284.00 |
| 29 Oct 2026 | Oppenheimer | BUY | $280.00 |
| 26 Oct 2026 | Piper Sandler | BUY | $238.00 |
No comments yet — be the first to weigh in on AXSM.
Sign in to join the discussion.